Published in J Membr Biol on May 27, 2012
Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Radiol Oncol (2012) 0.94
Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels. PLoS One (2013) 0.88
Modeling of microvascular permeability changes after electroporation. PLoS One (2015) 0.82
Differential cellular effects of electroporation and electrochemotherapy in monolayers of human microvascular endothelial cells. PLoS One (2012) 0.81
Electrotransfer parameters as a tool for controlled and targeted gene expression in skin. Mol Ther Nucleic Acids (2016) 0.75
Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J (1982) 17.98
Genetic immunization is a simple method for eliciting an immune response. Nature (1992) 5.30
Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst (2006) 4.27
Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer (2002) 3.96
Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol (2000) 2.54
Electrochemotherapy in treatment of tumours. Eur J Surg Oncol (2007) 2.51
Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol (2011) 2.25
DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer (2008) 2.23
In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers. PLoS One (2011) 1.71
Clinical applications of DNA vaccines: current progress. Clin Infect Dis (2011) 1.65
In vivo optical molecular imaging and analysis in mice using dorsal window chamber models applied to hypoxia, vasculature and fluorescent reporters. Nat Protoc (2011) 1.62
In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol (1998) 1.58
Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer (2008) 1.53
Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment. PLoS One (2009) 1.46
Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta (2002) 1.43
Nucleic acids electrotransfer-based gene therapy (electrogenetherapy): past, current, and future. Mol Biotechnol (2009) 1.40
Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther (2008) 1.39
Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation. J Virol (2008) 1.33
Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther (2010) 1.33
Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand? Curr Pharm Des (2006) 1.31
DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge. Proc Natl Acad Sci U S A (2009) 1.30
Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques. Mol Ther (2010) 1.28
Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge. J Infect Dis (2011) 1.25
Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther (2001) 1.22
Electroporation for DNA immunization: clinical application. Expert Rev Vaccines (2010) 1.21
Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques. Vaccine (2009) 1.09
The endothelial cytoskeleton as a target of electroporation-based therapies. Mol Cancer Ther (2006) 1.08
DNA electrotransfer into the skin using a combination of one high- and one low-voltage pulse. J Control Release (2005) 1.08
Electromobility of plasmid DNA in tumor tissues during electric field-mediated gene delivery. Gene Ther (2002) 1.07
Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem Biophys Res Commun (1999) 0.98
Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation. Vaccine (2000) 0.97
Numerical study of the electroporation pulse shape effect on molecular uptake of biological cells. Radiol Oncol (2010) 0.97
Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation. Vaccine (2010) 0.96
Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques. Vaccine (2010) 0.96
Evaluation of a novel non-penetrating electrode for use in DNA vaccination. PLoS One (2011) 0.96
Visualization of in vivo electroporation-mediated transgene expression in experimental tumors by optical and magnetic resonance imaging. Gene Ther (2009) 0.95
Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas. J Gene Med (2009) 0.95
Long-term programming of antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccine. PLoS One (2011) 0.93
DNA vaccines for targeting bacterial infections. Expert Rev Vaccines (2010) 0.92
Direct visualization at the single-cell level of siRNA electrotransfer into cancer cells. Proc Natl Acad Sci U S A (2011) 0.92
Safety and tolerability of the Easy Vax™ clinical epidermal electroporation system in healthy adults. Mol Ther (2011) 0.92
Estimation of apparent tumor vascular permeability from multiphoton fluorescence microscopic images of P22 rat sarcomas in vivo. Microcirculation (2008) 0.91
Muscle gene electrotransfer is increased by the antioxidant tempol in mice. Gene Ther (2011) 0.91
Antitumor therapeutic and antimetastatic activity of electroporation-delivered human papillomavirus 16 E7 DNA vaccines: a possible mechanism for enhanced tumor control. DNA Cell Biol (2011) 0.90
Gene transfer: how can the biological barriers be overcome? J Membr Biol (2010) 0.89
Review: Ischaemia-reperfusion injury in flap surgery. J Plast Reconstr Aesthet Surg (2009) 0.88
In vivo efficacy and safety of skin electroporation. Adv Drug Deliv Rev (1999) 0.87
Plasmid DNA vaccination using skin electroporation promotes poly-functional CD4 T-cell responses. Immunol Cell Biol (2010) 0.87
Spatial compartmentation and time resolution of photooxidation of a cell membrane probe in electropermeabilized Chinese hamster ovary cells. Eur J Biochem (1995) 0.87
In vivo assessment of skin electroporation using square wave pulses. J Control Release (2002) 0.84
MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo. Cancer Gene Ther (2010) 0.84
Electric field-mediated transport of plasmid DNA in tumor interstitium in vivo. Bioelectrochemistry (2007) 0.84
Non invasive contact electrodes for in vivo localized cutaneous electropulsation and associated drug and nucleic acid delivery. J Control Release (2008) 0.84
Efficacy of transgene expression in porcine skin as a function of electrode choice. Bioelectrochemistry (2011) 0.83
Enhancement of electric field-mediated gene delivery through pretreatment of tumors with a hyperosmotic mannitol solution. Cancer Gene Ther (2010) 0.82
Electrolysis and thermolysis for permanent hair removal. J Am Acad Dermatol (1985) 0.81
Immunization with a new DNA vaccine for Alzheimer's disease elicited Th2 immune response in BALB/c mice by in vivo electroporation. J Neurol Sci (2011) 0.80
Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res (2011) 2.24
Direct visualization at the single-cell level of electrically mediated gene delivery. Proc Natl Acad Sci U S A (2002) 1.90
Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res (2005) 1.59
Comparison of various techniques used to estimate spontaneous baroreflex sensitivity (the EuroBaVar study). Am J Physiol Regul Integr Comp Physiol (2003) 1.51
Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma. Cancer Biol Ther (2009) 1.47
Intravital microscopy at the single vessel level brings new insights of vascular modification mechanisms induced by electropermeabilization. J Control Release (2012) 1.46
Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. Biomed Eng Online (2010) 1.44
Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther (2010) 1.33
FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1. Cancer Res (2010) 1.31
Effect of electric field induced transmembrane potential on spheroidal cells: theory and experiment. Eur Biophys J (2003) 1.28
Electrochemotherapy of chest wall breast cancer recurrence. Cancer Treat Rev (2012) 1.27
Magnetic nanoparticles as targeted delivery systems in oncology. Radiol Oncol (2011) 1.19
Tumor size and effectiveness of electrochemotherapy. Radiol Oncol (2013) 1.14
Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models. Mol Cancer Ther (2008) 1.14
Electro-mediated gene transfer and expression are controlled by the life-time of DNA/membrane complex formation. J Gene Med (2010) 1.11
Intraoperative electrochemotherapy of colorectal liver metastases. J Surg Oncol (2014) 1.11
The effect of high frequency electric pulses on muscle contractions and antitumor efficiency in vivo for a potential use in clinical electrochemotherapy. Bioelectrochemistry (2004) 1.11
The endothelial cytoskeleton as a target of electroporation-based therapies. Mol Cancer Ther (2006) 1.08
Effect of electric field vectoriality on electrically mediated gene delivery in mammalian cells. Biochim Biophys Acta (2004) 1.06
Cancer electrogene therapy with interleukin-12. Curr Gene Ther (2010) 1.06
Robustness of treatment planning for electrochemotherapy of deep-seated tumors. J Membr Biol (2010) 1.05
Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis. Int J Cancer (2010) 1.03
Electrotransfer of therapeutic molecules into tissues. Curr Opin Mol Ther (2007) 0.99
Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector. Cancer Gene Ther (2002) 0.99
The effect of electroporation pulses on functioning of the heart. Med Biol Eng Comput (2008) 0.99
Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother (2015) 0.99
Increased cellular uptake of biocompatible superparamagnetic iron oxide nanoparticles into malignant cells by an external magnetic field. J Membr Biol (2010) 0.98
New insights in the visualization of membrane permeabilization and DNA/membrane interaction of cells submitted to electric pulses. Biochim Biophys Acta (2005) 0.97
Development of human cell biosensor system for genotoxicity detection based on DNA damage-induced gene expression. Radiol Oncol (2010) 0.96
Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas. J Gene Med (2009) 0.95
Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Radiol Oncol (2012) 0.94
Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy. Anticancer Drugs (2005) 0.93
A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor. J Exp Med (2011) 0.92
Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. Hum Gene Ther Clin Dev (2013) 0.92
Cancer cells regulate lymphocyte recruitment and leukocyte-endothelium interactions in the tumor-draining lymph node. Cancer Res (2005) 0.92
Finite-element modeling of needle electrodes in tissue from the perspective of frequent model computation. IEEE Trans Biomed Eng (2003) 0.91
Surface modified magnetic nanoparticles for immuno-gene therapy of murine mammary adenocarcinoma. Biomaterials (2012) 0.91
Multiple delivery of siRNA against endoglin into murine mammary adenocarcinoma prevents angiogenesis and delays tumor growth. PLoS One (2013) 0.90
Radiosensitising effect of electrochemotherapy with bleomycin in LPB sarcoma cells and tumors in mice. BMC Cancer (2005) 0.90
Effective treatment of multiple unresectable skin melanoma metastases by electrochemotherapy. Croat Med J (2007) 0.90
Electrogene therapy with interleukin-12 in canine mast cell tumors. Radiol Oncol (2010) 0.89
Optimisation of pulse parameters in vitro for in vivo electrochemotherapy. Anticancer Res (2002) 0.89
Long term expression of bicistronic vector driven by the FGF-1 IRES in mouse muscle. BMC Biotechnol (2007) 0.89
Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels. PLoS One (2013) 0.88
Fluorescence imaging agents in cancerology. Radiol Oncol (2010) 0.87
In vivo imaging of tumor growth after electrochemotherapy with cisplatin. Biochem Biophys Res Commun (2006) 0.87
Gene electrotransfer into murine skeletal muscle: a systematic analysis of parameters for long-term gene expression. Technol Cancer Res Treat (2008) 0.86
Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival. PLoS One (2009) 0.86
Electric pulses used in electrochemotherapy and electrogene therapy do not significantly change the expression profile of genes involved in the development of cancer in malignant melanoma cells. BMC Cancer (2009) 0.86
Radiotherapy in combination with vascular-targeted therapies. Radiol Oncol (2010) 0.86
Cell hybridization by electrofusion on filters. Anal Biochem (2002) 0.85
LNA-based oligonucleotide electrotransfer for miRNA inhibition. Mol Ther (2012) 0.84
Dynamic contrast enhanced MRI of mouse fibrosarcoma using small-molecular and novel macromolecular contrast agents. Phys Med (2007) 0.84
Non invasive contact electrodes for in vivo localized cutaneous electropulsation and associated drug and nucleic acid delivery. J Control Release (2008) 0.84
Electroporation of LPB sarcoma cells in vitro and tumors in vivo increases the radiosensitizing effect of cisplatin. Anticancer Res (2003) 0.84
The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer. FASEB J (2010) 0.84
Limb sparing treatment of bleeding melanoma recurrence by electrochemotherapy. Tumori (2009) 0.83
Coupling treatment planning with navigation system: a new technological approach in treatment of head and neck tumors by electrochemotherapy. Biomed Eng Online (2015) 0.83
EPR oximetry of tumors in vivo in cancer therapy. Spectrochim Acta A Mol Biomol Spectrosc (2004) 0.83
Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages. Cancer Lett (2012) 0.83
Effects of electrogenetherapy with p53wt combined with cisplatin on curvival of human tumor cell lines with different p53 status. DNA Cell Biol (2003) 0.83